What is the calcium-phosphorus product?

It is serum calcium multiplied by serum phosphate, both in mg/dL, giving units of mg squared per dL squared. In chronic kidney disease a high product reflects an excess of mineral that can deposit in blood vessels and soft tissue, driving calcification.

What threshold is considered elevated?

A Ca x P product above 55 mg squared per dL squared is the classic threshold associated with increased vascular and soft-tissue calcification risk in dialysis patients. Some guidelines treat values above 70 as markedly high and a trigger for urgent management.

How do you convert mmol/L to mg/dL?

Calcium in mmol/L is multiplied by 4.0 to get mg/dL, and phosphate in mmol/L is multiplied by 3.1. These factors come from the atomic and molecular weights and let the product be computed in the conventional mg-based units regardless of how the lab reports values.

Why is this product clinically useful?

It condenses two of the mineral-bone-disorder labs into one number that correlates with the risk of metastatic calcification, calciphylaxis, and cardiovascular events. It guides phosphate binder use, dietary phosphate restriction, and dialysis adjustments.

Is the product still recommended on its own?

Current KDIGO guidance emphasises treating calcium and phosphate individually rather than the product alone, because the product can be normal while one component is dangerously abnormal. The product remains a useful at-a-glance flag but should never replace the individual values.

What is the Calcium–Phosphorus Product Calculator?

Multiply serum calcium and phosphate, with unit-aware mg/dL or mmol/L conversion, to yield the Ca x P product and flag elevated vascular calcification risk above 55 mg2/dL2 in CKD. Used in nephrology. Runs in your browser. It runs free in your browser on Gera Tools, with nothing uploaded.

Calcium–Phosphorus Product Calculator

Name: Calcium–Phosphorus Product Calculator
Creator: Gera Tools
License: https://creativecommons.org/licenses/by/4.0/

Get one useful tool a week

Like this tool? Enter your email and we'll send you one genuinely useful Gera tool a week — plus a link to come back to this one. No spam, one-click unsubscribe any time.

The calcium-phosphorus product is a quick bedside number used in chronic kidney disease to gauge how much mineral is circulating and therefore how strongly the patient is being pushed toward calcification of blood vessels and soft tissues. It multiplies two routine labs into a single risk indicator.

How it works

The product is simply serum calcium times serum phosphate, expressed in mg/dL:

Ca x P product = calcium (mg/dL) x phosphate (mg/dL)

Because many laboratories report in SI units, the tool converts first:

calcium  (mmol/L) x 4.0 = calcium  (mg/dL)
phosphate(mmol/L) x 3.1 = phosphate(mg/dL)

The result carries units of mg squared per dL squared. A value above 55 is the conventional elevated-risk threshold in dialysis patients, and above 70 is treated as markedly high.

Worked example

For illustration: a patient with serum calcium of 9.5 mg/dL and serum phosphate of 6.5 mg/dL gives a product of 9.5 × 6.5 = 61.75 mg²/dL² — above the 55 threshold, flagging elevated vascular calcification risk. If the same labs were reported in SI (calcium 2.37 mmol/L, phosphate 2.10 mmol/L), the tool converts first: 2.37 × 4.0 = 9.48 mg/dL and 2.10 × 3.1 = 6.51 mg/dL, then multiplies to give approximately the same product.

Interpretation and clinical context

A rising product in a dialysis patient signals that phosphate control, calcium load, or vitamin D dosing needs attention, because mineral is being driven out of the blood and into vessel walls. Management includes phosphate binders, dietary phosphate restriction, and dialysis adjustment.

What drives the product up

High phosphate is the most common driver in dialysis patients because the kidneys normally excrete phosphate and dialysis clears it incompletely. Dietary restriction of phosphate-rich foods (dairy, processed meats, cola drinks) is a first step.
High calcium can result from calcium-based phosphate binders (calcium carbonate, calcium acetate) or active vitamin D analogues. Switching to non-calcium binders or adjusting vitamin D dosing may be needed.
Elevated parathyroid hormone (PTH) in secondary hyperparathyroidism mobilises both calcium and phosphate from bone, pushing the product upward. Calcimimetics or parathyroidectomy can be part of management.

Limitations of the product as a single metric

Modern KDIGO guidance stresses that you should still treat calcium and phosphate individually. The product can read normal while one component is dangerously off — for example, a low calcium combined with very high phosphate can yield a moderate product that still requires urgent intervention. Use the Ca × P product as an at-a-glance screen; always review the individual values alongside it.

This calculator is an educational aid and does not replace clinical judgement. Always interpret the Ca × P product alongside individual lab values, clinical history, and the full mineral bone disorder panel including PTH and vitamin D levels.